Vasculopathies : behavioral, chemical, environmental, and genetic factors /: behavioral, chemical, environmental, and genetic factors. ([2018])

• Record Type: Book
• Further Information: Note: Marc Thiriet.
• Authors: Thiriet, Marc
• Contents: Intro; Preface; Organ and Physiological Apparatus; Blood Flow; Gas Transport; Modeling; Mechanical Investigations; Book Series; Book Organization; Acknowledgments; Contents; 1 Cardiovascular Disease: An Introduction; 1.1 Vasculopathies and Vasculitides; 1.1.1 Ethnic Differences; 1.1.2 Gender Influence; 1.1.2.1 Estrogen Signaling; 1.1.2.2 Androgen Signaling; 1.1.2.3 Enzymes of Steroid Hormone Metabolism; 1.1.3 Vasculitis (Angiitis); 1.1.4 Vascular Wall Disorders; 1.1.4.1 Hemostasis and Thrombosis; 1.1.4.2 Inflammation and Angiogenesis; 1.1.4.3 Oxidative and Nitrosative Stresses; 1.1.4.4 Aging 1.1.4.5 Sleep Disorders1.1.4.6 Vascular Tumors and Malformations; 1.1.4.7 Ectopic Vascular Calcification; 1.1.5 Atherosclerosis; 1.2 Vasculopathies and Cardiac Dysfunction; 1.2.1 Cardiac Wall Remodeling; 1.2.1.1 Cardiac Wall Hypertrophy; 1.2.1.2 Cardiac Wall Fibrosis; 1.2.2 Cardiomyocyte Remodeling; 1.2.2.1 Energy Metabolism; 1.2.2.2 Ion Carriers; 1.2.2.3 Transverse Tubules; 1.2.2.4 Mitochondrion; 1.2.3 Altered Signaling; 1.2.4 Interrelation Between the Heart and Kidney; 1.2.5 Ectopic Calcification; 1.3 Autoimmune Disorders; 1.4 Congenital Vascular Malformations 2 Cardiovascular Risk Factors and Markers2.1 Environmental Stressors; 2.1.1 Air Pollution; 2.1.1.1 Airborne Pollutants; 2.1.1.2 Determinants of Air Pollution Exposure; 2.1.1.3 Aerosol Classification; 2.1.1.4 Air Filtration; 2.1.1.5 Biological Mechanisms; 2.1.1.6 Cardiovascular Events; 2.1.2 Noise; 2.2 Transcripts; 2.2.1 MicroRNAs; 2.2.1.1 Endothelial Mechanical Stress-Responsive MicroRNAs; 2.2.1.2 Regulators of Vascular Smooth Myocyte Phenotype; 2.2.1.3 Platelet MicroRNAs; 2.2.1.4 Hepatic MicroRNAs Operating in Metabolism; 2.2.1.5 MicroRNAs and Mitochondrial Function and Dysfunction 2.2.1.6 MicroRNAs as Risk Markers2.2.1.7 MicroRNAs Involved in Adverse Cardiac Remodeling; 2.2.1.8 MicroRNAs in Obesity and Diabetes; 2.2.1.9 MicroRNAs Involved in Atherosclerosis; 2.2.1.10 MicroRNAs Involved in Stroke; 2.2.2 Circular RNAs; 2.2.3 YRNAs; 2.2.4 Long Nonprotein-Coding RNAs; 2.2.4.1 Endothelial Long Nonprotein-Coding RNAs; 2.2.4.2 Long Nonprotein-Coding RNAs and Mitochondrial Function; 2.2.4.3 Long Nonprotein-Coding RNAs in Adverse Cardiac Remodeling; 2.2.5 Ribosomal RNA; 2.3 Clinical Types of Markers; 2.3.1 Screening; 2.3.1.1 Hemostasis Factors; 2.3.1.2 Periodontitis
• Publisher Details: Cham, Switzerland : Springer
• Publication Date: 2018
• Copyright Date: 2018
• Extent: 1 online resource
• Subjects: 616.13; Cardiology; Blood-vessels -- Diseases; HEALTH & FITNESS / Diseases / General; MEDICAL / Clinical Medicine; MEDICAL / Diseases; MEDICAL / Evidence-Based Medicine; MEDICAL / Internal Medicine; Electronic books; Electronic books
• Languages: English
• ISBNs: 9783319893150; 3319893157
• Related ISBNs: 9783319893143
• Notes: Note: Online resource; title from PDF title page (EBSCO, viewed February 21, 2019).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.